CaDAnCe-101
BeOne Medicines
BeOne Medicines
Sellas Life Sciences Group
Galapagos NV
University of Chicago
Juno Therapeutics, a Subsidiary of Celgene
Allogene Therapeutics
Genmab
Genmab
Genmab
National Institutes of Health Clinical Center (CC)
Medical University of South Carolina
Medical College of Wisconsin
BeOne Medicines
Dana-Farber Cancer Institute
Vironexis Biotherapeutics Inc.
Dana-Farber Cancer Institute
AstraZeneca
Acerta Pharma BV
AstraZeneca
Incyte Corporation
AstraZeneca
Ohio State University Comprehensive Cancer Center
Eli Lilly and Company
Novartis
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
BeOne Medicines
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Acerta Pharma BV
BeOne Medicines
CRISPR Therapeutics
AVM Biotechnology Inc
MingSight Pharmaceuticals, Inc
Sichuan Baili Pharmaceutical Co., Ltd.
University of California, San Diego
Genentech, Inc.
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Dana-Farber Cancer Institute
Ottawa Hospital Research Institute
M.D. Anderson Cancer Center
University of Utah
Mayo Clinic
IDP Discovery Pharma S.L.
M.D. Anderson Cancer Center
BeiGene
Ascentage Pharma Group Inc.
Memorial Sloan Kettering Cancer Center
MingSight Pharmaceuticals, Inc
Aprea Therapeutics